Business Description
Shandong Wit Dyne Health Co Ltd
NAICS : 325412
SIC : 2834
ISIN : CNE000000Z28
Share Class Description:
SZSE:000915: Class ACompare
Compare
Traded in other countries / regions
000915.China IPO Date
1999-06-09Description
Shandong Wit Dyne Health Co Ltd is engaged in the pharmaceutical industry. The product portfolio includes Azithromycin Granules, Rosiglitazone Tartrate Tablets, Lanso (roxithromycin), Yi Kexin-over 1 year old among others.
Financial Strength
10/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Cash-To-Debt | 1280.15 | |||||
| Equity-to-Asset | 0.6 | |||||
| Interest Coverage | 61.3 | |||||
| Piotroski F-Score | 9/9 | |||||
| Altman Z-Score | 9.68 | |||||
| Beneish M-Score | -2.5 | |||||
| WACC vs ROIC | ||||||
Growth Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 3-Year Revenue Growth Rate | 11 | |||||
| 3-Year EBITDA Growth Rate | 27.3 | |||||
| 3-Year EPS without NRI Growth Rate | 29.4 | |||||
| 3-Year FCF Growth Rate | 21.1 | |||||
| 3-Year Book Growth Rate | 15.2 | |||||
| Future 3-5Y EPS without NRI Growth Rate | 14.89 | |||||
| Future 3-5Y Total Revenue Growth Rate | 14.13 |
Momentum Rank
2/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| 5-Day RSI | 49.27 | |||||
| 9-Day RSI | 54.87 | |||||
| 14-Day RSI | 56.27 | |||||
| 6-1 Month Momentum % | -32.97 | |||||
| 12-1 Month Momentum % | -25.85 |
Liquidity Ratio
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Current Ratio | 6.42 | |||||
| Quick Ratio | 6.23 | |||||
| Cash Ratio | 5.23 | |||||
| Days Inventory | 103.16 | |||||
| Days Sales Outstanding | 11.51 | |||||
| Days Payable | 36.78 |
Dividend & Buy Back
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Dividend Yield % | 8.39 | |||||
| Dividend Payout Ratio | 0.78 | |||||
| 3-Year Dividend Growth Rate | 38.7 | |||||
| Forward Dividend Yield % | 8.39 | |||||
| 5-Year Yield-on-Cost % | 28.79 | |||||
| Shareholder Yield % | 8.34 |
Profitability Rank
9/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| Gross Margin % | 86.28 | |||||
| Operating Margin % | 52.02 | |||||
| Net Margin % | 23.95 | |||||
| FCF Margin % | 38.22 | |||||
| ROE % | 20.45 | |||||
| ROA % | 11.97 | |||||
| ROIC % | 67.41 | |||||
| ROC (Joel Greenblatt) % | 148.09 | |||||
| ROCE % | 30.8 | |||||
| Years of Profitability over Past 10-Year | 10 |
GF Value Rank
8/10
| Name | Current | Vs Industry | Vs History | |||
|---|---|---|---|---|---|---|
| PE Ratio | 12.05 | |||||
| Forward PE Ratio | 9.33 | |||||
| PE Ratio without NRI | 12.05 | |||||
| Shiller PE Ratio | 21.5 | |||||
| Price-to-Owner-Earnings | 13.78 | |||||
| PEG Ratio | 0.34 | |||||
| PS Ratio | 2.93 | |||||
| PB Ratio | 2.53 | |||||
| Price-to-Tangible-Book | 2.72 | |||||
| Price-to-Free-Cash-Flow | 7.59 | |||||
| Price-to-Operating-Cash-Flow | 7.21 | |||||
| EV-to-EBIT | 2.99 | |||||
| EV-to-EBITDA | 2.99 | |||||
| EV-to-Revenue | 1.61 | |||||
| EV-to-FCF | 4.24 | |||||
| Price-to-Projected-FCF | 0.7 | |||||
| Price-to-Median-PS-Value | 0.76 | |||||
| Price-to-Peter-Lynch-Fair-Value | 0.48 | |||||
| Price-to-Graham-Number | 1.21 | |||||
| Price-to-Net-Current-Asset-Value | 5.25 | |||||
| Price-to-Net-Cash | 9.46 | |||||
| Earnings Yield (Greenblatt) % | 33.44 | |||||
| FCF Yield % | 13.59 | |||||
| Forward Rate of Return (Yacktman) % | 31.03 |
Historical Operating Revenue by Business Segment
Historical Operating Revenue by Geographic Region
Guru Trades
See DetailsInsider Trades
See DetailsPeter Lynch Chart
Performance
Dividend
Log
Bar
Annualized Return % Â
Total Annual Return % Â
Shandong Wit Dyne Health Co Ltd Executives
DetailsAnalyst Estimate
Key Statistics
| Name | Value | ||
|---|---|---|---|
| Revenue (TTM) (Mil ¥) | 2,485.361 | ||
| EPS (TTM) (Â¥) | 2.55 | ||
| Beta | 0.97 | ||
| Volatility % | 41.83 | ||
| 14-Day RSI | 56.27 | ||
| 14-Day ATR (Â¥) | 1.568511 | ||
| 20-Day SMA (Â¥) | 28.1375 | ||
| 12-1 Month Momentum % | -25.85 | ||
| 52-Week Range (Â¥) | 23.61 - 37.08 | ||
| Shares Outstanding (Mil) | 234.33 |
Piotroski F-Score Details
Year:
| Component | Result | ||
|---|---|---|---|
| Piotroski F-Score | 9 | ||
| Positive ROA | |||
| Positive CFROA | |||
| Higher ROA yoy | |||
| CFROA > ROA | |||
| Lower Leverage yoy | |||
| Higher Current Ratio yoy | |||
| Less Shares Outstanding yoy | |||
| Higher Gross Margin yoy | |||
| Higher Asset Turnover yoy |
Shandong Wit Dyne Health Co Ltd Filings
| Filing Date | Document Date | Form | ||
|---|---|---|---|---|
| No Filing Data | ||||
Shandong Wit Dyne Health Co Ltd Stock Events
| Event | Date | Price(Â¥) | ||
|---|---|---|---|---|
| No Event Data | ||||
Shandong Wit Dyne Health Co Ltd Frequently Asked Questions
What is Shandong Wit Dyne Health Co Ltd(SZSE:000915)'s stock price today?
The current price of SZSE:000915 is ¥30.74. The 52 week high of SZSE:000915 is ¥37.08 and 52 week low is ¥23.61.
When is next earnings date of Shandong Wit Dyne Health Co Ltd(SZSE:000915)?
The next earnings date of Shandong Wit Dyne Health Co Ltd(SZSE:000915) is .
Does Shandong Wit Dyne Health Co Ltd(SZSE:000915) pay dividends? If so, how much?
The Dividend Yield %  of Shandong Wit Dyne Health Co Ltd(SZSE:000915) is 8.39% (As of Today), Highest Dividend Payout Ratio of Shandong Wit Dyne Health Co Ltd(SZSE:000915) was 0.78. The lowest was 0.09. And the median was 0.25. The  Forward Dividend Yield % of Shandong Wit Dyne Health Co Ltd(SZSE:000915) is 8.39%. For more information regarding to dividend, please check our Dividend Page.
Press Release
| Subject | Date | |||
|---|---|---|---|---|
| No Press Release | ||||
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers